In a patient with a mediastinal recurrence following lobectomy for early stage NSCLC, what would be your treatment volume?
Would anyone consider elective mediastinal XRT to 45-50Gy then boost involved LN to 60-66? Or treat involved lymph node only? The patient will receive concurrent chemotherapy also. Any thoughts or suggestions would be greatly appreciated!
2 Answers
Mednet MemberInvited Expert
Radiation Oncology · Duke University Medical Center
Answered on · Updated on
In a patient who develops an isolated failure in a regional nodal site after surgery, I would treat in a manner similar to inoperable stage III NSCLC (concurrent chemotherapy and radiation therapy). Under most circumstances, I would include some "selective" elective nodal coverage based on a number ...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center
Answered on
When there is a relapse post surgery, salvage is a long shot. Dealing with post lobectomy versus post pneumonectomy provides different caveats. My/our goal at the University of Michigan dose escalation trial was practical: elective nodes made the target too large to conduct a dose escalation trial. ...
Join for free or sign in to see the full answer